三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
美国约5500万肥胖患者的保险覆盖Wegovy
美国约5500万肥胖患者的保险覆盖Wegovy
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:341KB
图片尺寸:1592*1016
同报告图片
/
4
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
所属报告:
医药行业:美国医药调研及JPM大会后反馈-260205(17页).pdf
打包全文图表
相关数据
Wegovy(24年)和Zepbound1年维持率超60%
fCBZZWFyICAgICAgIHwgT3ZlcmFsbCAlIFBlcnNpc3RlbnQgYXQgMSBZZWFyIChOKSB8IFNlbWFnbHV0aWRlIChXZWdvdnkpICUgUGVyc2lzdGVudCBhdCAxIFllYXIgKE4pIHwgVGlyemVwYXRpZGUgKFplcGJvdW5kKSAlIFBlcnNpc3RlbnQgYXQgMSBZZWFyIChOKSB8CnwtLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwKfCAyMDIxICAgICAgIHwgMzMuMiUgKDg4OSkgICAgICAgICAgICAgICAgICAgICAgICB8IDMzLjIlICg4ODkpICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8IE5BICgwKSAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwKfCAyMDIyICAgICAgIHwgMzQuMSUgKDIsNDgwKSAgICAgICAgICAgICAgICAgICAgICB8IDM0LjElICgyLDQ4MCkgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8IE5BICgwKSAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwKfCAyMDIzICAgICAgIHwgNDAuNCUgKDE0LDY2NCkgICAgICAgICAgICAgICAgICAgICB8IDQwLjAlICgxNCw0MjgpICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8IDY0LjAlICgyMzYpICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwKfCAxUTIwMjQgICAgIHwgNjIuNiUgKDQsOTkyKSAgICAgICAgICAgICAgICAgICAgICB8IDYyLjclICgzLDMzOSkgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8IDYyLjYlICgxLDY1MykgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwKCuadpea6kO+8mlByaW1l77yM5Zu96YeR6K+B5Yi456CU56m25omA
收藏
行业数据
2025-11-19
原图定位
查看详情
司美格鲁肽减重产品Wegovy快速放量(百万美元)
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
收藏
行业数据
2025-06-20
原图定位
查看详情
品牌司美格鲁肽减肥版本(Wegovy)的滴定剂量和价格
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
收藏
行业数据
2025-03-06
原图定位
查看详情
Saxenda+Wegovy21年销售额合计84亿丹麦克朗,15-21年CAGR62.3%
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
收藏
行业数据
2022-10-11
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
就商保渠道而言,礼来和诺和诺德在近期 JPM 会议都明确指出当前几个显著的问题,(1)覆盖率不高:目前拥有商业保险的人群中,不到 60%的人群被覆盖;(2)可及性差:保险公司普遍通过事前授权、使用条件限制等方式对肥胖治疗药物的可及性加以管控,导致大量符合医学标准的患者并不能仅因肥胖状态或持有保险而轻易获得相关药物;(3)自付额高:有的患者年自付额高达 5000 美金,和自费一年的费用差不多。在这种背景下,大量患者由于无法获得保险报销,不得不承担现金支付,这直接形成了 GLP-1 自费渠道的商业化机会。
行业数据
原图定位
当前图表所属:
医药行业:美国医药调研及JPM大会后反馈-260205(17页).pdf
2026年医药行业报告:JPM大会反馈,创新药投资情绪显著修复
医药行业:美国医药调研及JPM大会后反馈-260205
口服是自免赛道另一个差异化竞争领域,多条技术路径值得关注
下一代双抗/多抗产品有望迭代一代单抗注射剂,催生下一轮自免BD风口
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》